BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34201898)

  • 41. Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU, and inhibits the formation of pancreatic cancer stem like cells.
    Cho JH; Kim SA; Park SB; Kim HM; Song SY
    Oncotarget; 2017 Sep; 8(44):76398-76407. PubMed ID: 29100320
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Sasaki N; Toyoda M; Yoshimura H; Matsuda Y; Arai T; Takubo K; Aida J; Ishiwata T
    Oncotarget; 2018 Oct; 9(78):34719-34734. PubMed ID: 30410672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of Mitochondrial Dynamics Preferentially Targets Pancreatic Cancer Cells with Enhanced Tumorigenic and Invasive Potential.
    Courtois S; de Luxán-Delgado B; Penin-Peyta L; Royo-García A; Parejo-Alonso B; Jagust P; Alcalá S; Rubiolo JA; Sánchez L; Sainz B; Heeschen C; Sancho P
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
    Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U
    Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of cancer cell stemness by chemotherapy.
    Hu X; Ghisolfi L; Keates AC; Zhang J; Xiang S; Lee DK; Li CJ
    Cell Cycle; 2012 Jul; 11(14):2691-8. PubMed ID: 22732500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer stem cell-like characteristics and telomerase activity of the nasopharyngeal carcinoma radioresistant cell line CNE-2R.
    Chen KH; Guo Y; Li L; Qu S; Zhao W; Lu QT; Mo QY; Yu BB; Zhou L; Lin GX; Sun YC; Zhu XD
    Cancer Med; 2018 Sep; 7(9):4755-4764. PubMed ID: 30105829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells.
    Chen J; Zhao J; Ding J; Wang Z; Du J; Wu C
    Braz J Med Biol Res; 2020; 53(7):e9230. PubMed ID: 32520208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. c-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells.
    Zhang HL; Wang P; Lu MZ; Zhang SD; Zheng L
    Oncol Lett; 2019 May; 17(5):4487-4493. PubMed ID: 30944638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hedgehog Signaling Regulates Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem-Like Cells.
    Wang F; Ma L; Zhang Z; Liu X; Gao H; Zhuang Y; Yang P; Kornmann M; Tian X; Yang Y
    J Cancer; 2016; 7(4):408-17. PubMed ID: 26918054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells.
    Gao W; Wu D; Wang Y; Wang Z; Zou C; Dai Y; Ng CF; Teoh JY; Chan FL
    Stem Cell Res Ther; 2018 Sep; 9(1):243. PubMed ID: 30257704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.
    Quan MY; Guo Q; Liu J; Yang R; Bai J; Wang W; Cai Y; Han R; Lv YQ; Ding L; Billadeau DD; Lou Z; Bellusci S; Li X; Zhang JS
    Front Cell Dev Biol; 2020; 8():287. PubMed ID: 32457900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
    Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
    Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
    Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
    Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase.
    Sarveswaran S; Varma NRS; Morisetty S; Ghosh J
    Oncotarget; 2019 Jan; 10(4):424-436. PubMed ID: 30728896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness.
    Katsura Y; Ohara T; Noma K; Ninomiya T; Kashima H; Kato T; Sato H; Komoto S; Narusaka T; Tomono Y; Xing B; Chen Y; Tazawa H; Kagawa S; Shirakawa Y; Kasai T; Seno M; Matsukawa A; Fujiwara T
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-449a maintains self-renewal in liver cancer stem-like cells by targeting
    Zhang Q; Yang Z; Shan J; Liu L; Liu C; Shen J; Chen X; Xu Y; Chen J; Ma Q; Yang L; Qian C
    Oncotarget; 2017 Dec; 8(66):110187-110200. PubMed ID: 29299140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
    Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
    EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.